v3.25.1
RESTRUCTURING AND OTHER COSTS (Tables)
 3 Months Ended
Mar. 31, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Costs
Restructuring and other costs were recorded in the Consolidated Statements of Operations as follows:
Three Months Ended March 31,
(in millions)20252024
Cost of products sold$— $— 
Selling, general, and administrative expenses1 3 
Restructuring and other costs9 1 
Total restructuring and other costs$10 $4 
Schedule of Restructuring Accruals Activity in the Company’s restructuring accruals at March 31, 2025 was as follows:
Severance
(in millions)2023 and Prior Plans2024 PlansOther ActionsTotal
Balance at December 31, 2024$13 $19 $— $32 
Provisions— 2 6 8 
Amounts applied(6)(9)— (15)
Change in estimates(1)— — (1)
Balance at March 31, 2025$6 $12 $6 $24 
Other Restructuring Costs
(in millions)2023 and Prior Plans2024 PlansOther ActionsTotal
Balance at December 31, 2024$1 $— $— $1 
Provisions— — — — 
Amounts applied— — — — 
Balance at March 31, 2025$1 $— $— $1 
Schedule of Company’s Segment Information
The Company’s reportable segment information was as follows:
Three Months Ended March 31,
(in millions)2025
Connected Technology SolutionsEssential Dental SolutionsOrthodontic and Implant SolutionsWellspect HealthcareTotal
Net sales235 353 21774879
Adjusted cost of products sold (a)
$135 $124 9327
Adjusted selling expenses (b)
$57 $71 5413
Adjusted G&A expenses (b)
$19 $18 226
Adjusted R&D expenses (c)
$17 $5 112
Segment adjusted operating income$7 $135 3726205
Reconciling items (income) expense:
Unallocated corporate costs (d)
87
Interest expense, net19
Restructuring and other costs9
Amortization of intangibles45
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations1
Income before income taxes44
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, unallocated professional service fees, and other operating costs which are not assigned to a specific segment.
Three Months Ended March 31,
(in millions)2024
Connected Technology SolutionsEssential Dental SolutionsOrthodontic and Implant SolutionsWellspect HealthcareTotal
Net sales247 364 271 71 953 
Adjusted cost of products sold (a)
146 139 100 26 
Adjusted selling expenses (b)
62 83 83 13 
Adjusted G&A expenses (b)
18 21 33 6 
Adjusted R&D expenses (c)
19 6 13 3 
Segment adjusted operating income2 115 42 23 182 
Reconciling items (income) expense:
Unallocated corporate costs (d)
79 
Interest expense, net18 
Other (income) expense, net(7)
Goodwill and intangible asset impairments6 
Restructuring and other costs1 
Amortization of intangibles54 
Income before income taxes31 
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, unallocated professional service fees, and other operating costs which are not assigned to a specific segment.

Depreciation and Amortization
Three Months Ended March 31,
(in millions)20252024
Connected Technology Solutions4343 
Essential Dental Solutions98 
Orthodontic and Implant Solutions1925 
Wellspect Healthcare25 
All other (a)65 
Total7986 
(a) Includes unallocated corporate costs for depreciation and amortization.
The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows:
(in millions)December 31, 2024ProvisionsAmounts
Applied		Change in EstimatesMarch 31, 2025
Connected Technology Solutions$9 $2 $(7)$(1)$3 
Essential Dental Solutions11 (2)(3)— 6 
Orthodontic and Implant Solutions9 1 (2)— 8 
Wellspect Healthcare3 1 (1)— 3 
All Other1 6 (2)— 5 
Total$33 $8 $(15)$(1)$25